Live news related to TRANSGENE stock (FR0005175080): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Transgene announces the completion of patient randomization in the Phase 2 segment of its clinical trial evaluating TG4050, a personalized therapeutic…
Transgene and NEC Bio B.V., a subsidiary of NEC Corporation, have entered into a licensing agreement on April 2, 2026, to continue the clinical develo…
French biotech company Transgene raised 144 million euros in December 2025 (105 million through private placement and 39 million through debt conversi…
The biotechnology company based in Strasbourg, Transgene, revealed on Tuesday, February 4th in the late afternoon, the publication dates of its financ…
Biotechnology company Transgene announced on Thursday the addition of two new members to its scientific committee, Professor Antoine Italiano and Prof…
Strasbourg-based biotechnology group Transgene has announced the pre-publication on medRxiv of a detailed analysis of Phase I trial data evaluating TG…
At the close of trading on Friday, December 12, 2025, Transgene's stock marked a significant increase of 7.17%, reaching 0.96 euros from 0.89 euros th…
